Karen Knudsen: Thankful to Milken Institute for prioritizing discussion of early onset cancers
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of ACS, shared a post on LinkedIn:
“So thankful to Milken Institute for prioritizing discussion of early onset cancers – which are rapidly on the rise in the USA – as a key part of the MIHealth Summit. Idea exchange on our panel led to actionable proposals for how to understand, manage, and mitigate this disturbing trend.
Loved waving a ‘magic wand’ to outline concepts – now let’s do it!”
More posts featuring Karen Knudsen.
Karen E. Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.
She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers.
She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023